| Current Price | $12.52 | Mkt Cap | $2.3B |
|---|---|---|---|
| Open | $12.41 | P/E Ratio | 0.00 |
| Prev. Close | $12.52 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $12.32 - $12.68 | Volume | 2,146,775 |
| 52-Wk Range | $7.61 - $19.99 | Avg. Daily Vol. | 2,699,841 |
A biotechnology company, which designs, optimizes and develops novel drugs that block key enzymes involved in cancer, cardiovascular diseases, autoimmune diseases, and viral infections.
| Current Price | $12.52 | Mkt Cap | $2.3B |
|---|---|---|---|
| Open | $12.41 | P/E Ratio | 0.00 |
| Prev. Close | $12.52 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $12.32 - $12.68 | Volume | 2,146,775 |
| 52-Wk Range | $7.61 - $19.99 | Avg. Daily Vol. | 2,699,841 |
The best Bull and Bear pitches based on recency and number of recommendations.
Already profitable; growing; good pipeline
As I predicted, BioCryst still had a little life left which allowed me to escape my green thumb and flip turn into a red one. 33% jump today, and all because of this:BioCryst Pharmaceuticals, Inc. today announced that it received a preliminary… More
Read the most recent pitches from players about BCRX.
Recs
VladimirPoutine
(< 20)
Submitted: 2/6/2022 2:45:41 PM :
Start Price:
$14.89
NASDAQ:BCRX Score:
+3.26
Already profitable; growing; good pipeline
Recs
PensionExtender
(31.93)
Submitted: 6/30/2020 5:50:50 PM :
Start Price:
$4.90
NASDAQ:BCRX Score:
+138.19
COVID-19 biotech should continue to grow with oral delivery system of vaccine
Recs
mdriver78
(63.45)
Submitted: 5/8/2020 1:14:04 PM :
Start Price:
$4.36
NASDAQ:BCRX Score:
+166.24
Expecting positive sales of over $500 on Berotralstat approval. Plus early clinical data supports BCX9930 as oral monotherapy for complement-mediated diseases plus patient dosing underway in galidesivir trial in COVID-19 patients in Brazil. All sounds quite positive and worth a flyer.
Find the members with the highest scoring picks in BCRX.
cozynite (29.29) Score: +723.91
The Score Leader is the player with the highest score across all their picks in BCRX.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| cozynite | 29.29 | 3/14/2013 |
|
5Y | $1.31 | +855.73% | +131.81% | +723.91 | 0 Comment | |
| MrTwo94 | 90.73 | 11/8/2012 |
|
1Y | $1.37 | +813.87% | +160.03% | +653.83 | 0 Comment | |
| jgrnot | 32.01 | 12/4/2012 |
|
5Y | $1.41 | +788.01% | +157.05% | +630.95 | 0 Comment | |
| Sytes | < 20 | 5/29/2013 |
|
3Y | $1.60 | +682.50% | +119.63% | +562.87 | 1 Comment | |
| bearonwallstreet | 64.38 | 5/16/2013 |
|
5Y | $1.70 | +636.47% | +119.16% | +517.31 | 0 Comment | |
| warrenout3 | 38.26 | 12/3/2012 |
|
5Y | $1.63 | +668.10% | +154.43% | +513.67 | 0 Comment | |
| portefeuille2 | 98.80 | 2/16/2016 |
|
5Y | $1.87 | +569.52% | +91.54% | +477.98 | 0 Comment | |
| Bigsef77 | 56.51 |
|
|
5Y | $1.89 | +562.43% | +93.74% | +468.69 | 0 Comment | |
| Roger55125 | 30.31 | 4/24/2013 |
|
5Y | $1.80 | +595.56% | +130.20% | +465.36 | 0 Comment | |
| portefeuille | 98.23 |
|
|
NS | $1.92 | +552.42% | +93.72% | +458.70 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
